RCUS Latest Press Releases

-- November 4, 2026 --

Arcus Biosciences Reports Third-Quarter 2026 Financial Results and Provides a Pipeline Update Business Wire 4:05 PM

-- November 2, 2026 --

Arcus Biosciences to Participate in the Jefferies Global Healthcare Conference 2026 in London Business Wire 4:05 PM

-- October 26, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- October 21, 2026 --

Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock Business Wire 10:53 PM

Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firm PRNewswire 4:26 PM

Arcus Biosciences Announces Commencement of Public Offering of Common Stock Business Wire 4:22 PM

-- October 20, 2026 --

Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer Business Wire 8:30 AM

-- October 9, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- September 24, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- September 22, 2026 --

Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy Business Wire 8:30 AM

-- September 9, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- August 26, 2026 --

Arcus Biosciences to Participate in Three Upcoming Investor Conferences Business Wire 4:05 PM

-- August 19, 2026 --

Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firm PRNewswire 7:58 PM

-- August 11, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- August 5, 2026 --

Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update Business Wire 4:05 PM

-- July 27, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- July 22, 2026 --

Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients Business Wire 4:35 PM

Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer Business Wire 4:30 PM

Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer Business Wire 4:30 PM

-- July 21, 2026 --

Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates Business Wire 4:05 PM

-- July 9, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- July 1, 2026 --

New Research Published in Nature Links Clinical Activity with HIF-2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan Business Wire 11:00 AM

-- June 24, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

Market Data Delayed 15 Minutes